Antilipidemic drugs: medicinal, chemical and biochemical aspects
Saved in:
| Format: | Book |
|---|---|
| Language: | English |
| Published: |
Amsterdam u.a.
Elsevier
1991
|
| Series: | Pharmacochemistry library
17 |
| Subjects: | |
| Online Access: | Inhaltsverzeichnis |
| Physical Description: | XVI, 601 S. Ill., graph. Darst. |
| ISBN: | 0444891889 |
Staff View
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV004827746 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 920513s1991 ad|| |||| 00||| engod | ||
| 020 | |a 0444891889 |9 0-444-89188-9 | ||
| 035 | |a (OCoLC)25266601 | ||
| 035 | |a (DE-599)BVBBV004827746 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-355 | ||
| 050 | 0 | |a RC632.H87 | |
| 082 | 0 | |a 615.739 | |
| 084 | |a XI 4900 |0 (DE-625)153009:12905 |2 rvk | ||
| 245 | 1 | 0 | |a Antilipidemic drugs |b medicinal, chemical and biochemical aspects |c ed. by D. T. Witiak ... |
| 264 | 1 | |a Amsterdam u.a. |b Elsevier |c 1991 | |
| 300 | |a XVI, 601 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Pharmacochemistry library |v 17 | |
| 650 | 4 | |a Agents cardiovasculaires | |
| 650 | 4 | |a Lipides - Métabolisme, Troubles du | |
| 650 | 4 | |a Lipoprotéines - Métabolisme, Troubles du | |
| 650 | 4 | |a Antilipemic Agents |x chemistry | |
| 650 | 4 | |a Antilipemic Agents |x therapeutic use | |
| 650 | 4 | |a Antilipemic agents | |
| 650 | 4 | |a Arteriosclerosis |x physiopathology | |
| 650 | 4 | |a Lipid Metabolism | |
| 650 | 4 | |a Lipids |x Metabolism | |
| 650 | 4 | |a Lipoproteins |x Metabolism | |
| 650 | 4 | |a Lipoproteins |x metabolism | |
| 650 | 0 | 7 | |a Pharmakotherapie |0 (DE-588)4076066-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Lipidstoffwechselstörung |0 (DE-588)4035876-8 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Lipidsenker |0 (DE-588)4167796-1 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Lipidsenker |0 (DE-588)4167796-1 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Lipidstoffwechselstörung |0 (DE-588)4035876-8 |D s |
| 689 | 1 | 1 | |a Pharmakotherapie |0 (DE-588)4076066-2 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Witiak, Donald T. |e Sonstige |4 oth | |
| 830 | 0 | |a Pharmacochemistry library |v 17 |w (DE-604)BV001899371 |9 17 | |
| 856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=002970504&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-002970504 | ||
Record in the Search Index
| _version_ | 1804118938787774464 |
|---|---|
| adam_text | S PHARMACOCHEMISTRY LIBRARY EDITOR: H. TIMMERMAN VOLUME 17 ANTIUPIDEMIC
DRUGS MEDICINAL, CHEMICAL AND BIOCHEMICAL ASPECTS D.T. WITIAK COLLEGE OF
PHARMACY, THE OHIO STATE UNIVERSITY, COLUMBUS, OH 43210, U.S.A. H.A.I.
NEWMAN COLLEGE OF MEDICINE, THE OHIO STATE UNIVERSITY, COLUMBUS OH
43210, U.S.A. D.R. FELLER COLLEGE OF PHARMACY, THE OHIO STATE
UNIVERSITY, COLUMBUS OH 43210, U.S.A. ELSEVIER * AMSTERDAM * LONDON *
NEW YORK * TOKYO 1991 TABLE OF CONTENTS FOREWORD BY D.T. WITIAK, H.A.I.
NEWMAN AND D.R. FELLER VII LIST OF CONTRIBUTORS XI I I CHAPTER 1
PHYSIOLOGY AND PATHOPHYSIOLOGY OF LIPID AND LIPOPROTEIN METABOLISM BY
R.L. JACKSON 1 CHAPTER 2 EPIDEMIOLOGICAL SIGNIFICANCE OF LIPOPROTEINS IN
CORONARY HEART DISEASE (CHD) BY M.L. MOESCHBERGER 19 CHAPTER 3 THE
BIOCHEMISTRY OF THE ATHEROSCLEROTIC LESION BY A.J. MEROLA AND R.V.
PANGANAMALA 47 CHAPTER 4 MOLECULAR BIOLOGICAL APPROACHES TO THE
UNDERSTANDING OF LIPOPROTEIN METABOLISM BY J.M. ORDOVAS 97 CHAPTER 5
HMG-COA REDUCTASE INHIBITORS AND LIPID-LIPOPROTEIN METABOLISM BY R.L.
SMITH 121 CHAPTER 6 ACYL COA: CHOLESTEROL ACYLTRANSFERASE INHIBITORS AND
LIPID-LIPOPROTEIN METABOLISM BY F.G. KATHAWALA AND J.G. HEIDER 159
CHAPTER 7 CHEMISTRY AND PHARMACOLOGY OF BILE SALT SEQUESTRANTS BY L.M.
HAGERMAN AND C.E. DAY 197 CHAPTER 8 PHENOXYACETIC ACIDS AND
LIPID-LIPOPROTEIN METABOLISM BY B.D. ROTH AND R.S. NEWTON 225 CHAPTER 9
NICOTINIC ACID ANALOGS AND LIPID-LIPOPROTEIN METABOLISM BY R.A. PAKER
AND M. WEINER 257 CHAPTER 10 THE SYNTHESIS, METABOLISM, AND BIOLOGICAL
ACTIVITY OF PROBUCOL AND ITS ANALOGS BY J.W. BARNHART, E.R. WAGNER AND
R.L. JACKSON 277 CHAPTER 11 , EFFECTS OF ALPHA- AND BETA-ADRENOCEPTORS
ON LIPIDS AND LIPOPROTEINS BY J.P. HIEBLE AND R.R. RUFFOLO, JR 301
CHAPTER 12 DRUGS AFFECTING LIPOPROTEIN OXIDATION AND MODIFICATION BY
H.A.I. NEWMAN, A.T. HOPPER AND D.T. WITIAK 345 CHAPTER 13 HEPATIC
PEROXISOME PROLIFERATION INDUCED BY HYPOLIPIDEMIC DRUGS AND OTHER
CHEMICALS BY P.I. EACHO AND D.R. FELLER 375 CHAPTER 14
LIPOPROTEIN-PLATELET INTERACTIONS AND ANTILIPIDEMIC DRUGS BY K. ROMSTEDT
AND HUZOOR-AKBAR 427 CHAPTER 15 DIETARY REGULATION OF LIPID-LIPOPROTEIN
METABOLISM: EFFECTS UPON ATHEROSCLEROSIS BY S.L. CONNOR AND W.E. CONNOR
455 CHAPTER 16 HORMONAL REGULATION OF LIPOPROTEINS AND LIPOPROTEIN
METABOLISM BY R.W. BRUEGGEMEIER AND P.-K. LI 493 CHAPTER 17 NONINVASIVE
IMAGING METHODS FOR MONITORING THE FATE OF LIPOPROTEIN CONSTITUENTS IN
VIVO BY R.E. COUNSELL, L.E. DEFORGE, M.A. LONGINO, S.W. SCHWENDNER AND
J.P. WEICHERT 527 CHAPTER 18 CURRENT STATUS OF CLINICALLY EFFICACIOUS
DRUGS BY D. CANTER 573 ABBREVIATION LIST 597
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV004827746 |
| callnumber-first | R - Medicine |
| callnumber-label | RC632 |
| callnumber-raw | RC632.H87 |
| callnumber-search | RC632.H87 |
| callnumber-sort | RC 3632 H87 |
| callnumber-subject | RC - Internal Medicine |
| classification_rvk | XI 4900 |
| ctrlnum | (OCoLC)25266601 (DE-599)BVBBV004827746 |
| dewey-full | 615.739 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615.739 |
| dewey-search | 615.739 |
| dewey-sort | 3615.739 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02191nam a2200565 cb4500</leader><controlfield tag="001">BV004827746</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">920513s1991 ad|| |||| 00||| engod</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0444891889</subfield><subfield code="9">0-444-89188-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)25266601</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV004827746</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-355</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC632.H87</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.739</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 4900</subfield><subfield code="0">(DE-625)153009:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Antilipidemic drugs</subfield><subfield code="b">medicinal, chemical and biochemical aspects</subfield><subfield code="c">ed. by D. T. Witiak ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Amsterdam u.a.</subfield><subfield code="b">Elsevier</subfield><subfield code="c">1991</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XVI, 601 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Pharmacochemistry library</subfield><subfield code="v">17</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Agents cardiovasculaires</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lipides - Métabolisme, Troubles du</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lipoprotéines - Métabolisme, Troubles du</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antilipemic Agents</subfield><subfield code="x">chemistry</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antilipemic Agents</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antilipemic agents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Arteriosclerosis</subfield><subfield code="x">physiopathology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lipid Metabolism</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lipids</subfield><subfield code="x">Metabolism</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lipoproteins</subfield><subfield code="x">Metabolism</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lipoproteins</subfield><subfield code="x">metabolism</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Lipidstoffwechselstörung</subfield><subfield code="0">(DE-588)4035876-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Lipidsenker</subfield><subfield code="0">(DE-588)4167796-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Lipidsenker</subfield><subfield code="0">(DE-588)4167796-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Lipidstoffwechselstörung</subfield><subfield code="0">(DE-588)4035876-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Witiak, Donald T.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Pharmacochemistry library</subfield><subfield code="v">17</subfield><subfield code="w">(DE-604)BV001899371</subfield><subfield code="9">17</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=002970504&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-002970504</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV004827746 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T16:18:15Z |
| institution | BVB |
| isbn | 0444891889 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-002970504 |
| oclc_num | 25266601 |
| open_access_boolean | |
| owner | DE-12 DE-355 DE-BY-UBR |
| owner_facet | DE-12 DE-355 DE-BY-UBR |
| physical | XVI, 601 S. Ill., graph. Darst. |
| publishDate | 1991 |
| publishDateSearch | 1991 |
| publishDateSort | 1991 |
| publisher | Elsevier |
| record_format | marc |
| series | Pharmacochemistry library |
| series2 | Pharmacochemistry library |
| spelling | Antilipidemic drugs medicinal, chemical and biochemical aspects ed. by D. T. Witiak ... Amsterdam u.a. Elsevier 1991 XVI, 601 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Pharmacochemistry library 17 Agents cardiovasculaires Lipides - Métabolisme, Troubles du Lipoprotéines - Métabolisme, Troubles du Antilipemic Agents chemistry Antilipemic Agents therapeutic use Antilipemic agents Arteriosclerosis physiopathology Lipid Metabolism Lipids Metabolism Lipoproteins Metabolism Lipoproteins metabolism Pharmakotherapie (DE-588)4076066-2 gnd rswk-swf Lipidstoffwechselstörung (DE-588)4035876-8 gnd rswk-swf Lipidsenker (DE-588)4167796-1 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Lipidsenker (DE-588)4167796-1 s DE-604 Lipidstoffwechselstörung (DE-588)4035876-8 s Pharmakotherapie (DE-588)4076066-2 s Witiak, Donald T. Sonstige oth Pharmacochemistry library 17 (DE-604)BV001899371 17 GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=002970504&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Antilipidemic drugs medicinal, chemical and biochemical aspects Pharmacochemistry library Agents cardiovasculaires Lipides - Métabolisme, Troubles du Lipoprotéines - Métabolisme, Troubles du Antilipemic Agents chemistry Antilipemic Agents therapeutic use Antilipemic agents Arteriosclerosis physiopathology Lipid Metabolism Lipids Metabolism Lipoproteins Metabolism Lipoproteins metabolism Pharmakotherapie (DE-588)4076066-2 gnd Lipidstoffwechselstörung (DE-588)4035876-8 gnd Lipidsenker (DE-588)4167796-1 gnd |
| subject_GND | (DE-588)4076066-2 (DE-588)4035876-8 (DE-588)4167796-1 (DE-588)4143413-4 |
| title | Antilipidemic drugs medicinal, chemical and biochemical aspects |
| title_auth | Antilipidemic drugs medicinal, chemical and biochemical aspects |
| title_exact_search | Antilipidemic drugs medicinal, chemical and biochemical aspects |
| title_full | Antilipidemic drugs medicinal, chemical and biochemical aspects ed. by D. T. Witiak ... |
| title_fullStr | Antilipidemic drugs medicinal, chemical and biochemical aspects ed. by D. T. Witiak ... |
| title_full_unstemmed | Antilipidemic drugs medicinal, chemical and biochemical aspects ed. by D. T. Witiak ... |
| title_short | Antilipidemic drugs |
| title_sort | antilipidemic drugs medicinal chemical and biochemical aspects |
| title_sub | medicinal, chemical and biochemical aspects |
| topic | Agents cardiovasculaires Lipides - Métabolisme, Troubles du Lipoprotéines - Métabolisme, Troubles du Antilipemic Agents chemistry Antilipemic Agents therapeutic use Antilipemic agents Arteriosclerosis physiopathology Lipid Metabolism Lipids Metabolism Lipoproteins Metabolism Lipoproteins metabolism Pharmakotherapie (DE-588)4076066-2 gnd Lipidstoffwechselstörung (DE-588)4035876-8 gnd Lipidsenker (DE-588)4167796-1 gnd |
| topic_facet | Agents cardiovasculaires Lipides - Métabolisme, Troubles du Lipoprotéines - Métabolisme, Troubles du Antilipemic Agents chemistry Antilipemic Agents therapeutic use Antilipemic agents Arteriosclerosis physiopathology Lipid Metabolism Lipids Metabolism Lipoproteins Metabolism Lipoproteins metabolism Pharmakotherapie Lipidstoffwechselstörung Lipidsenker Aufsatzsammlung |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=002970504&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV001899371 |
| work_keys_str_mv | AT witiakdonaldt antilipidemicdrugsmedicinalchemicalandbiochemicalaspects |